Gene Editing Market Outlook and in-Depth Analysis 2020-2026 by Top Players Agilent Technologies, Origene, Integrated DNA Technologies, Thermo Fisher Scientific, Takara Bio, Sangamo Therapeutics, Origene Technologies

Graphical Research has released a new research study on gene editing market Analysis 2020-2026 inclusive of one or more factors covering regional opportunities, application landscape, product demand trends, and end-use portfolio of the industry over the forecast timeframe. The report also outlines the competitive framework of the industry detailing the SWOT analysis and market share dominance of the prominent players.

Thus, the emergence of next-generation crops is likely to assist the global market forecast over the coming times. The following seven trends have been setting the tone for the further advancement of the industry forecast through 2026.

Deployment across research institutes in North America

With growing number of innovations across genome editing technologies for therapeutic applications, the research institutes segment of the gene editing market in North America is likely to claim a major portion. The segment is slated to surge at a 15% CAGR through the forecast timeline, triggered by the growing prevalence of genetic disorders across the region.

Access sample pages of the report, “North America Gene Editing Market Forecasts 2026” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1518/sample

The regional gene editing market share is certain to prosper as several government grants and favorable policies have been encouraging research studies, due to which scientists and researchers can engage in research activities to a greater extent.

Plant-breeders in Canada to leverage benefits

The gene editing industry in Canada is projected to surge at a 14% CAGR through the forecast years, owing to the increasing adoption of this technology by plant breeders in the region. They have been focusing toward the development of new and productive plant varieties such as BT crops by leveraging genome editing. Additionally, the surging volume of government funds toward research activities has also been spurring expansion of the Canadian gene editing industry size.

High incidence of rare diseases in the U.S.

The U.S. market for genome editing held a share of over $1.2 billion during 2019 and is set to register a higher demand by 2026. The high frequency of rare diseases across the nation has been generating the need for advanced gene editing tools for development of new and effective drugs and treatments.

The findings of the Rare Genomics Institute reveal that nearly one out of ten individuals residing in the U.S. are diagnosed with a rare and genetic disease. Therefore, the high degree of focus on research activities for treating these diseases has led to a higher deployment of gene editing tools including ZFNs, CRISPER/Cas9, and TALENs in the past few years.

Chronic disorders rise across Germany

The German gene editing market forecast has been gaining momentum on account of the high incidence of chronic disorders across the region. The regional industry share is projected to surge at a 18.5% CAGR from 2020 to 2026, attaining a considerable revenue by 2026. The rising burden of diabetes, congestive heart failure, and other chronic conditions in the region has been paving the way for greater demand for gene therapies.

Access sample pages of the report, “Europe Gene Editing Market Forecasts 2026” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1515/sample

The Europe market forecast is expected to soar due to the presence of research institutes and organizations such as German Society for Gene Therapy, where discovery of issues pertaining to experimental and clinical gene therapy is the primary focus of scientists and doctors.

CRISPR technology to exhibit high demand in Europe

In terms of technology utilized, the Europe genome editing industry share has been categorized into CRISPR/Cas9, TALENs, and Zinc Finger Nucleases (ZFNs). Of these, the CRISPR technology claimed a share of over 46.5% during 2019 and is slated to expand further by 2026.

CRIPSR technology caters to the needs of patients who do not have multiple treatment options. Numerous patients have been opting for this technology as it can offer personalized medicine, which is designed as per the specific requirements of the individual.

Innovative genetic tests across India

The growing per capita incomes of individuals in India have been fueling the demand for genetic testing aimed at genetic disease detection and treatment. The expanding government expenditures toward healthcare alongside research in the areas of medicine and biotechnology has also been ensuring that the gene editing market in India maintains its growth pace through the upcoming years.

The high rate of birth across the country is expected to lead to a substantial number of babies with genetic diseases, supporting the progress of the market. The Asia Pacific market outlook is also benefitting from the utilization of gene editing tools for crop improvement. For instance, gene editing is being used for introducing salt tolerance (which can aid crops grow in saline water) across a popular rice variety cultivated over 3 million hectares across southern and eastern India.

Access sample pages of the report, “APAC Gene Editing Market Forecasts 2026” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1512/sample

Academic support to genome editing in Japan

During 2019, the market share from the Japanese gene editing market was estimated at $288 million. The region has been brimming with significant expansion opportunities since the past few years, driven by academic support offered by the research institutes in the region.

This extensive rise in the number of research initiatives is due to the increased awareness associated with the benefits of genome editing. The adherence to the guidelines laid down by the government bodies regarding the precise DNA modifications has also been accelerating the APAC market forecast of late.

Contact Us:

Parikhit B.
Corporate Sales,
Graphical Research
Phone: 1-800-986-6917
Email: sales@graphicalresearch.com
Web: https://www.graphicalresearch.com

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

This release was published on openPR.